Portfolio Holdings Detail for ISIN IE00BMX0DF60

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam

Holdings detail for ATRC

Show aggregate ATRC holdings

News associated with ATRC

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Brokerages

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-08-22 02:26:44

AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 46.1% in July

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,220,000 shares, anincreaseof46.1% from the July 15th total of 1,520,000 shares. Based on an average daily volume of 546,100 shares, the short-interest ratio is presently 4.1 days. […] - 2025-08-21 05:28:44

XTX Topco Ltd Makes New $526,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)

XTX Topco Ltd purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 16,301 shares of the medical device company’s stock, valued at approximately $526,000. A number of other hedge funds also recently bought and sold shares of the business. Hood River […] - 2025-08-07 05:01:01

Mackenzie Financial Corp Increases Position in AtriCure, Inc. (NASDAQ:ATRC)

Mackenzie Financial Corp lifted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 91.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,143 shares of the medical device company’s stock after acquiring an additional 13,929 shares during the quarter. Mackenzie Financial […] - 2025-08-06 05:07:47

AtriCure (NASDAQ:ATRC) Shares Gap Up on Strong Earnings

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $31.73, but opened at $37.70. AtriCure shares last traded at $37.03, with a volume of 594,302 shares traded. The medical device company reported ($0.02) […] - 2025-08-01 02:07:09

Allianz Asset Management GmbH Has $3.96 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)

Allianz Asset Management GmbH lifted its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 22.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 122,858 shares of the medical device company’s stock after acquiring an additional 22,838 shares during the period. Allianz Asset Management GmbH owned […] - 2025-07-29 04:44:56

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Analysts

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock […] - 2025-07-28 03:06:51

Mackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC)

Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company’s stock, valued at approximately $465,000. Other institutional investors and hedge funds have also […] - 2025-06-04 05:16:59

AtriCure (NASDAQ:ATRC) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of AtriCure (NASDAQ:ATRC – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. A number of other analysts also recently weighed in on ATRC. Piper Sandler upped their target price on shares of AtriCure from $40.00 to $50.00 and gave the […] - 2025-06-02 04:26:45

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical device company’s stock after selling 101,207 shares during the […] - 2025-05-30 05:35:00

State of Wyoming Acquires 446 Shares of AtriCure, Inc. (NASDAQ:ATRC)

State of Wyoming boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,481 shares of the medical device company’s stock after buying an additional 446 shares during the period. State of Wyoming’s holdings in AtriCure were worth $76,000 at the end […] - 2025-05-29 05:08:55

ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)

ProShare Advisors LLC grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,330 shares of the medical device company’s stock after purchasing an additional 4,385 shares during the quarter. ProShare […] - 2025-05-28 05:13:03

Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC)

Man Group plc purchased a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,368 shares of the medical device company’s stock, valued at approximately $745,000. Other institutional investors and hedge funds […] - 2025-05-26 05:01:05

AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street Zen

AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other analysts have also commented on ATRC. Stifel Nicolaus boosted their price objective on shares of AtriCure from $36.00 to $48.00 and gave […] - 2025-05-26 02:12:50

ATRC Crosses Below Key Moving Average Level

In trading on Friday, shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $32.37, changing hands as low as $31.95 per share. AtriCure Inc shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of - 2025-05-23 12:36:54

Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)

Nuveen Asset Management LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 12.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,037,348 shares of the medical device company’s stock after selling 149,584 shares during the quarter. Nuveen Asset Management LLC’s holdings in AtriCure were worth $31,701,000 as of its most recent […] - 2025-05-22 05:58:59

BNP Paribas Financial Markets Has $2.97 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)

BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 676.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,310 shares of the medical device company’s stock after buying an additional 84,776 […] - 2025-05-16 06:02:57

Northern Trust Corp Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC)

Northern Trust Corp grew its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,607 shares of the medical device company’s stock after purchasing an additional 50,153 shares during the […] - 2025-05-16 04:38:56

Dimensional Fund Advisors LP Raises Position in AtriCure, Inc. (NASDAQ:ATRC)

Dimensional Fund Advisors LP increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 24.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700,212 shares of the medical device company’s stock after acquiring an additional 136,015 shares during the quarter. Dimensional Fund Advisors LP’s holdings in AtriCure were worth $21,398,000 […] - 2025-05-08 04:45:00

Barclays PLC Has $2.64 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)

Barclays PLC trimmed its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company’s stock after selling 42,724 shares during the quarter. Barclays PLC’s holdings in AtriCure were worth […] - 2025-05-01 05:14:58

AtriCure (NASDAQ:ATRC) Trading Up 4.9% After Better-Than-Expected Earnings

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price traded up 4.9% on Tuesday following a stronger than expected earnings report. The company traded as high as $35.19 and last traded at $35.31. 373,568 shares were traded during mid-day trading, a decline of 43% from the average session volume of 654,896 shares. The stock had […] - 2025-05-01 02:40:58

Envestnet Asset Management Inc. Cuts Position in AtriCure, Inc. (NASDAQ:ATRC)

Envestnet Asset Management Inc. decreased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,086 shares of the medical device company’s stock after selling 2,104 shares during the period. Envestnet Asset Management […] - 2025-04-30 04:42:56

Raymond James Financial Inc. Acquires Shares of 121,591 AtriCure, Inc. (NASDAQ:ATRC)

Raymond James Financial Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 121,591 shares of the medical device company’s stock, valued at approximately $3,716,000. Several other hedge […] - 2025-04-27 06:26:45

AtriCure (NASDAQ:ATRC) and KORU Medical Systems (NASDAQ:KRMD) Financial Survey

AtriCure (NASDAQ:ATRC – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares AtriCure […] - 2025-04-22 02:50:55

Townsquare Capital LLC Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC)

Townsquare Capital LLC decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 16,138 shares of the medical device company’s stock after selling 789 shares during the period. Townsquare Capital LLC’s holdings in AtriCure were worth $493,000 […] - 2025-04-21 05:26:42

JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)

JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 04:39:04

Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC)

Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 04:32:51

Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56

Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 04:56:46

Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC)

Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 04:34:46

Analysts See 32% Gains Ahead For The Holdings of ESML

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-12 09:42:28

iShares US Medical Devices UCITS ETF ATRC holdings

Date	Number of ATRC Shares Held	Base Market Value of ATRC Shares	Local Market Value of ATRC Shares	Change in ATRC Shares Held	Change in ATRC Base Value	Current Price per ATRC Share Held	Previous Price per ATRC Share Held
2025-09-18 (Thursday)	6,577	USD 241,113	USD 241,113	0	USD 10,852	USD 36.66	USD 35.01
2025-09-17 (Wednesday)	6,577	USD 230,261	USD 230,261	0	USD -6,248	USD 35.01	USD 35.96
2025-09-16 (Tuesday)	6,577	USD 236,509	USD 236,509
2025-09-15 (Monday)	6,577	USD 227,762	USD 227,762
2025-09-12 (Friday)	6,577	USD 230,655	USD 230,655
2025-09-11 (Thursday)	6,577	USD 247,032	USD 247,032	0	USD 15,850	USD 37.56	USD 35.1501
2025-09-10 (Wednesday)	6,577	USD 231,182	USD 231,182	0	USD -6,313	USD 35.1501	USD 36.1099

Share Trades of ATRC by Blackrock for IE00BMX0DF60

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-06-27	SELL	-110			32.280*		34.63 Profit of 3,809 on sale
2025-06-12	BUY	162			32.330*		34.79
2025-06-10	SELL	-864			33.390*		34.81 Profit of 30,080 on sale
2025-06-09	SELL	-1,026			34.180*		34.82 Profit of 35,725 on sale
2025-05-30	SELL	-108			34.570*		34.83 Profit of 3,761 on sale
2025-05-19	BUY	54			32.400*		34.95
2025-05-09	SELL	-285			30.990*		35.12 Profit of 10,008 on sale
2025-04-23	SELL	-57			32.490*		35.57 Profit of 2,028 on sale
2025-04-17	SELL	-56			32.010*		35.73 Profit of 2,001 on sale
2025-04-10	BUY	448			31.640*		35.94
2025-04-04	SELL	-112			31.310*		36.14 Profit of 4,048 on sale
2025-04-02	SELL	-112			34.130*		36.17 Profit of 4,051 on sale
2025-03-31	SELL	-168			32.260*		36.25 Profit of 6,090 on sale
2025-03-19	SELL	-54			34.820*		36.49 Profit of 1,970 on sale
2025-02-28	SELL	-108			38.740*		36.75 Profit of 3,969 on sale
2025-02-05	BUY	168			41.330*		35.41
2025-02-04	BUY	224			40.650*		35.28
2025-01-29	SELL	-55			42.400*		34.72 Profit of 1,910 on sale
2025-01-23	SELL	-56			40.370*		33.99 Profit of 1,903 on sale
2025-01-02	SELL	-108			30.400*		34.09 Profit of 3,682 on sale
2024-12-04	BUY	162			36.310*		34.02
2024-12-03	SELL	-54			36.120*		33.94 Profit of 1,833 on sale
2024-12-02	SELL	-648			37.060*		33.82 Profit of 21,915 on sale
2024-11-29	SELL	-1,080			36.160*		33.73 Profit of 36,425 on sale
2024-11-27	SELL	-162			36.170*		33.51 Profit of 5,429 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATRC

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer